Multiple Sclerosis Patients and Disease Modifying Therapies: Impact on Immune Responses against COVID-19 and SARS-CoV-2 Vaccination
- PMID: 35214735
- PMCID: PMC8876554
- DOI: 10.3390/vaccines10020279
Multiple Sclerosis Patients and Disease Modifying Therapies: Impact on Immune Responses against COVID-19 and SARS-CoV-2 Vaccination
Abstract
This article reviews the literature on SARS-CoV-2 pandemic and multiple sclerosis (MS). The first part of the paper focuses on the current data on immunopathology of SARS-CoV-2 and leading vaccines produced against COVID-19 infection. In the second part of the article, we discuss the effect of Disease Modifying Therapies (DMTs) on COVID-19 infection severity or SARS-CoV-2 vaccination in MS patients plus safety profile of different vaccine platforms in MS patients.
Keywords: COVID-19; DMTs; SARS-CoV-2; immunosuppression; multiple sclerosis; vaccine.
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Alam T., Qamar S. Coronavirus Disease (COVID-19): Reviews, Applications, and Current Status. J. Inform. Univ. Pamulang. 2020;5:213–219. doi: 10.32493/informatika.v5i3.6563. - DOI
-
- Coronavirus Worldometers [Internet] 2022. [(accessed on 1 February 2022)]. Available online: https://www.worldometers.info/coronavirus/
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
